189 related articles for article (PubMed ID: 27503276)
1. Allosteric HIV-1 integrase inhibitors promote aberrant protein multimerization by directly mediating inter-subunit interactions: Structural and thermodynamic modeling studies.
Deng N; Hoyte A; Mansour YE; Mohamed MS; Fuchs JR; Engelman AN; Kvaratskhelia M; Levy R
Protein Sci; 2016 Nov; 25(11):1911-1917. PubMed ID: 27503276
[TBL] [Abstract][Full Text] [Related]
2. A critical role of the C-terminal segment for allosteric inhibitor-induced aberrant multimerization of HIV-1 integrase.
Shkriabai N; Dharmarajan V; Slaughter A; Kessl JJ; Larue RC; Feng L; Fuchs JR; Griffin PR; Kvaratskhelia M
J Biol Chem; 2014 Sep; 289(38):26430-26440. PubMed ID: 25118283
[TBL] [Abstract][Full Text] [Related]
3. The A128T resistance mutation reveals aberrant protein multimerization as the primary mechanism of action of allosteric HIV-1 integrase inhibitors.
Feng L; Sharma A; Slaughter A; Jena N; Koh Y; Shkriabai N; Larue RC; Patel PA; Mitsuya H; Kessl JJ; Engelman A; Fuchs JR; Kvaratskhelia M
J Biol Chem; 2013 May; 288(22):15813-20. PubMed ID: 23615903
[TBL] [Abstract][Full Text] [Related]
4. The Drug-Induced Interface That Drives HIV-1 Integrase Hypermultimerization and Loss of Function.
Singer MR; Dinh T; Levintov L; Annamalai AS; Rey JS; Briganti L; Cook NJ; Pye VE; Taylor IA; Kim K; Engelman AN; Kim B; Perilla JR; Kvaratskhelia M; Cherepanov P
mBio; 2023 Feb; 14(1):e0356022. PubMed ID: 36744954
[TBL] [Abstract][Full Text] [Related]
5. Structural Basis for Inhibitor-Induced Aggregation of HIV Integrase.
Gupta K; Turkki V; Sherrill-Mix S; Hwang Y; Eilers G; Taylor L; McDanal C; Wang P; Temelkoff D; Nolte RT; Velthuisen E; Jeffrey J; Van Duyne GD; Bushman FD
PLoS Biol; 2016 Dec; 14(12):e1002584. PubMed ID: 27935939
[TBL] [Abstract][Full Text] [Related]
6. A New Class of Allosteric HIV-1 Integrase Inhibitors Identified by Crystallographic Fragment Screening of the Catalytic Core Domain.
Patel D; Antwi J; Koneru PC; Serrao E; Forli S; Kessl JJ; Feng L; Deng N; Levy RM; Fuchs JR; Olson AJ; Engelman AN; Bauman JD; Kvaratskhelia M; Arnold E
J Biol Chem; 2016 Nov; 291(45):23569-23577. PubMed ID: 27645997
[TBL] [Abstract][Full Text] [Related]
7. Optimizing the Multimerization Properties of Quinoline-Based Allosteric HIV-1 Integrase Inhibitors.
Sun J; Kessl JJ
Viruses; 2024 Jan; 16(2):. PubMed ID: 38399977
[TBL] [Abstract][Full Text] [Related]
8. The mechanism of H171T resistance reveals the importance of Nδ-protonated His171 for the binding of allosteric inhibitor BI-D to HIV-1 integrase.
Slaughter A; Jurado KA; Deng N; Feng L; Kessl JJ; Shkriabai N; Larue RC; Fadel HJ; Patel PA; Jena N; Fuchs JR; Poeschla E; Levy RM; Engelman A; Kvaratskhelia M
Retrovirology; 2014 Nov; 11():100. PubMed ID: 25421939
[TBL] [Abstract][Full Text] [Related]
9. Molecular modeling study on the allosteric inhibition mechanism of HIV-1 integrase by LEDGF/p75 binding site inhibitors.
Xue W; Liu H; Yao X
PLoS One; 2014; 9(3):e90799. PubMed ID: 24599328
[TBL] [Abstract][Full Text] [Related]
10. Optimized binding of substituted quinoline ALLINIs within the HIV-1 integrase oligomer.
Sun J; Patel K; Hume J; Pigza JA; Donahue MG; Kessl JJ
J Biol Chem; 2021; 296():100363. PubMed ID: 33539919
[TBL] [Abstract][Full Text] [Related]
11. Computational design of small molecular modulators of protein-protein interactions with a novel thermodynamic cycle: Allosteric inhibitors of HIV-1 integrase.
Sun Q; Ramaswamy VSK; Levy R; Deng N
Protein Sci; 2021 Feb; 30(2):438-447. PubMed ID: 33244804
[TBL] [Abstract][Full Text] [Related]
12. Multi-Substituted Quinolines as HIV-1 Integrase Allosteric Inhibitors.
Dinh LP; Sun J; Glenn CD; Patel K; Pigza JA; Donahue MG; Yet L; Kessl JJ
Viruses; 2022 Jul; 14(7):. PubMed ID: 35891446
[TBL] [Abstract][Full Text] [Related]
13. The Competitive Interplay between Allosteric HIV-1 Integrase Inhibitor BI/D and LEDGF/p75 during the Early Stage of HIV-1 Replication Adversely Affects Inhibitor Potency.
Feng L; Dharmarajan V; Serrao E; Hoyte A; Larue RC; Slaughter A; Sharma A; Plumb MR; Kessl JJ; Fuchs JR; Bushman FD; Engelman AN; Griffin PR; Kvaratskhelia M
ACS Chem Biol; 2016 May; 11(5):1313-21. PubMed ID: 26910179
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 integrase tetramers are the antiviral target of pyridine-based allosteric integrase inhibitors.
Koneru PC; Francis AC; Deng N; Rebensburg SV; Hoyte AC; Lindenberger J; Adu-Ampratwum D; Larue RC; Wempe MF; Engelman AN; Lyumkis D; Fuchs JR; Levy RM; Melikyan GB; Kvaratskhelia M
Elife; 2019 May; 8():. PubMed ID: 31120420
[TBL] [Abstract][Full Text] [Related]
15. Allosteric integrase inhibitor potency is determined through the inhibition of HIV-1 particle maturation.
Jurado KA; Wang H; Slaughter A; Feng L; Kessl JJ; Koh Y; Wang W; Ballandras-Colas A; Patel PA; Fuchs JR; Kvaratskhelia M; Engelman A
Proc Natl Acad Sci U S A; 2013 May; 110(21):8690-5. PubMed ID: 23610442
[TBL] [Abstract][Full Text] [Related]
16. Allosteric HIV Integrase Inhibitors Promote Formation of Inactive Branched Polymers via Homomeric Carboxy-Terminal Domain Interactions.
Gupta K; Allen A; Giraldo C; Eilers G; Sharp R; Hwang Y; Murali H; Cruz K; Janmey P; Bushman F; Van Duyne GD
Structure; 2021 Mar; 29(3):213-225.e5. PubMed ID: 33357410
[TBL] [Abstract][Full Text] [Related]
17. Structure of a HIV-1 IN-Allosteric inhibitor complex at 2.93 Å resolution: Routes to inhibitor optimization.
Eilers G; Gupta K; Allen A; Montermoso S; Murali H; Sharp R; Hwang Y; Bushman FD; Van Duyne G
PLoS Pathog; 2023 Mar; 19(3):e1011097. PubMed ID: 36867659
[TBL] [Abstract][Full Text] [Related]
18. Allosteric inhibition of HIV-1 integrase activity.
Engelman A; Kessl JJ; Kvaratskhelia M
Curr Opin Chem Biol; 2013 Jun; 17(3):339-45. PubMed ID: 23647983
[TBL] [Abstract][Full Text] [Related]
19. Indole-based allosteric inhibitors of HIV-1 integrase.
Patel PA; Kvaratskhelia N; Mansour Y; Antwi J; Feng L; Koneru P; Kobe MJ; Jena N; Shi G; Mohamed MS; Li C; Kessl JJ; Fuchs JR
Bioorg Med Chem Lett; 2016 Oct; 26(19):4748-4752. PubMed ID: 27568085
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure of the HIV-1 integrase core domain in complex with sucrose reveals details of an allosteric inhibitory binding site.
Wielens J; Headey SJ; Jeevarajah D; Rhodes DI; Deadman J; Chalmers DK; Scanlon MJ; Parker MW
FEBS Lett; 2010 Apr; 584(8):1455-62. PubMed ID: 20227411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
